Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Welch

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Haematologica|December 1, 2020
Expanding dasatinib beyond KIT in acute myeloid leukemiaJohn S Welch
Blood|April 14, 2022
TP53 and the star-crossed lovers MDS and AMLJohn S Welch
Best Practice & Research. Clinical Haematology|November 24, 2018
Patterns of mutations in TP53 mutated AMLJohn S Welch
Seminars in Hematology|October 15, 2014
Mutation position within evolutionary subclonal architecture in AMLJohn S Welch
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 14, 2003
Genomics and inductive reasoning: revolution, renaissance, or rhetoric?John S Welch, Gerhard Rogler
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genomics of AML: clinical applications of next-generation sequencingJohn S Welch, Daniel C Link
Haematologica|February 24, 2022
A sheep in wolf's clothing? Wild-type P53 disguises as mutant to promote leukemogenesisMargaret A Ferris, John S Welch
Cancers|December 7, 2019
Retinoic Acid Receptors in Acute Myeloid Leukemia TherapyOrsola di Martino, John S Welch
ACS Omega|September 5, 2022
Quantum Interstate Phase Differences and Multiphoton Processes: Quantum Jumps or Dynamic Beats?Randall B Shirts, John S Welch
The Journal of Clinical Investigation|March 3, 2011
PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in miceJohn S Welch, Wenlin Yuan, Timothy J Ley
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Haematologica|December 1, 2020
Expanding dasatinib beyond KIT in acute myeloid leukemiaJohn S Welch
Blood|April 14, 2022
TP53 and the star-crossed lovers MDS and AMLJohn S Welch
Best Practice & Research. Clinical Haematology|November 24, 2018
Patterns of mutations in TP53 mutated AMLJohn S Welch
Seminars in Hematology|October 15, 2014
Mutation position within evolutionary subclonal architecture in AMLJohn S Welch
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 14, 2003
Genomics and inductive reasoning: revolution, renaissance, or rhetoric?John S Welch, Gerhard Rogler
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genomics of AML: clinical applications of next-generation sequencingJohn S Welch, Daniel C Link
Haematologica|February 24, 2022
A sheep in wolf's clothing? Wild-type P53 disguises as mutant to promote leukemogenesisMargaret A Ferris, John S Welch
Cancers|December 7, 2019
Retinoic Acid Receptors in Acute Myeloid Leukemia TherapyOrsola di Martino, John S Welch
ACS Omega|September 5, 2022
Quantum Interstate Phase Differences and Multiphoton Processes: Quantum Jumps or Dynamic Beats?Randall B Shirts, John S Welch
The Journal of Clinical Investigation|March 3, 2011
PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in miceJohn S Welch, Wenlin Yuan, Timothy J Ley
Pageof 8